Short description
DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.
Description
IFM Therapeutics is a provider of small molecule that module novel targets in the innate immune system. The company and its academic collaborators combine unparalleled expertise in innate immunity with seasoned drug discovery and development professionals. Its subsidiary IFM Due is focused on the discovery and developing antagonists of the cGAS/STING pathway for the treatment of inflammation, neuroinflammation, autoimmunity and cancer. IFM Discovery, a newly financed incubator entity within the IFM enterprise, is prosecuting a basket of genetically-validated targets as next-generation therapies for inflammation, neuroinflammation, autoimmunity and fibrosis
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2015
Exited on
August 3, 2017
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccess, Noaccess, Blurry Noaccess
Sign in for full access
Founders
Anthony Opipari, Eicke Latz, Gary Glick, Luigi Franchi, Matthias Geyer